RETRACTED: Effect of Previous Cancer History on Survival of Patients with Different Subtypes of Breast Cancer (Retracted Article)

被引:2
|
作者
Lin, Weixun [1 ]
Chen, Yaokun [1 ]
Ji, Zeqi [1 ]
Chen, Lingzhi [1 ]
Wu, Jinyao [1 ]
Chen, Yexi [1 ]
Li, Zhiyang [1 ]
机构
[1] Shantou Univ Med Coll, Hosp 2, Dept Thyroid Breast & Hernia Surg, Shantou 515041, Guangdong, Peoples R China
关键词
ELIGIBILITY CRITERIA; TRIAL ELIGIBILITY; AGE; STRATEGIES; ADJUVANT; THERAPY; STAGE; WOMEN; RACE;
D O I
10.1155/2022/6116658
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Patients with a previous cancer history (PCA) are routinely excluded from most clinical trials, which may limit the accuracy and universality of clinical trials. We aimed to explore the association between PCA and survival of patients with different molecular subtypes of breast cancer. Patients diagnosed with breast cancer from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2015 were included in this retrospective cohort study. The primary outcome was overall survival (OS), which was calculated from date of diagnosis to date of death or censor date during this period. The relationship between PCA and OS of patients with different molecular subtypes of breast cancer was analyzed by the Kaplan-Meier curves and multivariate Cox proportional-hazards model. A total of 35,640 primary breast cancer patients were included, and 2,038 (5.72%) patients had a PCA. Female genital system cancer (491 cases, 24.09%) was the largest proportion type of previous cancer, and HER2-positive (24,754 cases, 69.46%) breast cancer was the most common subtype. Patients with previous female genital/endocrine system cancer history and other cancers history were associated with a poorer OS in overall patients, and in patients with triple-negative and HER2-positive subtypes (P < 0.05). In patients with Luminal A and Luminal B subtypes, previous other cancers history was related to poor OS (P < 0.05), while female genital/endocrine system cancer history may not influence the OS (P > 0.05). Subgroup analyses presented that PCA was related to poor OS in patients aged 40-64 years and & GE;65 years (P < 0.05), while prognosis in patients aged 18-40 years may not be influenced by PCA (P > 0.05). The impact of PCA on the prognosis of breast cancer patients was related to molecular type, patient age, and type of PCA. In clinical trials of breast cancer, the exclusion criteria for PCA patients may be modified according to the above variables.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] RETRACTED: Machine Learning Algorithms for Prediction of Survival Curves in Breast Cancer Patients (Retracted Article)
    Maabreh, Roqia Saleem Awad
    Alazzam, Malik Bader
    AlGhamdi, Ahmed S.
    APPLIED BIONICS AND BIOMECHANICS, 2021, 2021
  • [2] RETRACTION: Effect of Previous Cancer History on Survival of Patients with Different Subtypes of Breast Cancer (Retraction of Vol 2022, art no 6116658, 2022)
    Lin, W.
    Chen, Y.
    Ji, Z.
    BIOMED RESEARCH INTERNATIONAL, 2024, 2024
  • [3] RETRACTED: Methylation of the RASSFIA promoter in breast cancer (Retracted Article)
    Ji, Y.
    Jin, H. H.
    Wang, M. D.
    Cao, W. X.
    Bao, J. L.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (02):
  • [4] RETRACTED: Depression and health related quality of life in breast cancer patients (Retracted Article)
    Ardebil, Maryam Didehdar
    Bouzari, Zinnatossadat
    Shenas, Mohsen Hagh
    Keighobadi, Masoud
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2013, 63 (01) : 69 - 71
  • [5] RETRACTED: An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer (Retracted Article)
    Salter, Kelly H.
    Acharya, Chaitanya R.
    Walters, Kelli S.
    Redman, Richard
    Anguiano, Ariel
    Garman, Katherine S.
    Anders, Carey K.
    Mukherjee, Sayan
    Dressman, Holly K.
    Barry, William T.
    Marcom, Kelly P.
    Olson, John
    Nevins, Joseph R.
    Potti, Anil
    PLOS ONE, 2008, 3 (04):
  • [6] RETRACTED: Changes and Influencing Factors of Cognitive Impairment in Patients with Breast Cancer (Retracted Article)
    Cui, Huixia
    Shi, Xusheng
    Song, Xiaoxiu
    Zhang, Wenlu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [7] RETRACTED: The lncRNA Signatures of Genome Instability to Predict Survival in Patients with Renal Cancer (Retracted Article)
    Huang, Liang
    Xie, Yu
    Jiang, Shusuan
    Han, Weiqing
    Zeng, Fanchang
    Li, Daoyuan
    JOURNAL OF HEALTHCARE ENGINEERING, 2021, 2021
  • [8] RETRACTED: Overexpression of Cosmc suppresses cell migration and invasion in different subtypes of breast cancer cells via Tn and T glycans (Retracted Article)
    Liu, Jun
    Xu, Feng
    Li, Jie
    Jiang, Hongchuan
    BIOSCIENCE REPORTS, 2020, 40
  • [9] RETRACTED ARTICLE: Undertreatment of breast cancer in the elderly
    Nicola Rocco
    Corrado Rispoli
    Gennaro Pagano
    Silvio Ascione
    Rita Compagna
    Michele Danzi
    Antonello Accurso
    Bruno Amato
    BMC Surgery, 13
  • [10] RETRACTED: Prognostic Diagnosis for Breast Cancer Patients Using Probabilistic Bayesian Classification (Retracted Article)
    Junath, N.
    Bharadwaj, Alok
    Tyagi, Sachin
    Sengar, Kalpana
    Hasan, Mohammad Najmus Saquib
    Jayasudha, M.
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022